Novartis ready to head for deep space with Voyager after a year 'kicking the tires'

It’s been a year since Novartis ventured into orbit with Voyager Therapeutics to find new central nervous system targets. Now, the Big Pharma is ready to go deeper into space with the adeno-associated virus (AAV) capsid discovery biotech.